Status:
WITHDRAWN
Cell Salvage During Caesarean Section (CSCS)
Lead Sponsor:
Wenzhou Medical University
Conditions:
Blood Transfusion
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purposes of this study are: 1. To compare the difference of blood loss of the patients undergoing cesarean section between intraoperative blood recovery and allogeneic blood transfusion. 2. To co...
Detailed Description
Preoperative: 1.To select patients according to the criteria.2.To obtain the consent of the obstetrician, the anesthesiologist, and the patients. Intraoperative:According to local blood transfusion g...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Delivery by elective or emergency caesarean section with an identifiable increased risk of haemorrhage.
- Ability to provide informed consent
- Participants need blood transfusion
Exclusion
- Hb\<70g/L before operation
- Participants have a history of blood transfusion
- Blood type is RH blood type
- Sickle cell disease
- The obstetricians and anesthesia doctors think some cases existing intraoperatie blood recycling contraindications
- PT and APTT is 1.5 times longer than normal and above, or platelet is less than 50 \* 109 / L preoperative
- Cultural or social beliefs contraindicating blood transfusion.
- Significant antibodies making it difficult to find cross matched blood for transfusion
- participation in another clinical trial within 3 months prior to selection
- ability to provide informed consent
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03429790
Start Date
November 1 2018
End Date
December 31 2018
Last Update
July 18 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.